( carbohydrate |
natural product |
sugar )
*Laboratory for Biosynthetic Chemistry, Pharmaceutical Sciences Division, and
Edited by Kyriacos C. Nicolaou, The Scripps Research Institute, La Jolla, CA, and approved June 24, 2005 (received for review April 20, 2005) Glycosylated natural products are reliable platforms for the development of many front-line drugs, yet our understanding of the relationship between attached sugars and biological activity is limited by the availability of convenient glycosylation methods. When a universal chemical glycosylation method that employs reducing sugars and requires no protection or activation is used, the glycorandomization of digitoxin leads to analogs that display significantly enhanced potency and tumor specificity and suggests a divergent mechanistic relationship between cardiac glycoside-induced cytotoxicity and Na+/K+-ATPase inhibition. This report highlights the remarkable advantages of glycorandomization as a powerful tool in glycobiology and drug discovery.
Chemistry
Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization
,
, 
,
¶
University of Wisconsin National Cooperative Drug Discovery Group Program, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705;
Keck University of Wisconsin Comprehensive Cancer Center Small Molecule Screening Facility, K6/569, 600 Highland Avenue, Madison, WI 53705; and
X-Ray Crystallography Laboratory, Department of Chemistry, University of Wisconsin, 1101 University Avenue, Madison, WI 53706
Author contributions: J.M.L. and J.S.T. designed research; J.M.L., N.R.P., and I.A.G. performed research; J.M.L., N.R.P., I.A.G., F.M.H., and J.S.T. analyzed data; J.M.L. and J.S.T. wrote the paper; I.A.G. performed crystallography and analysis only; and F.M.H. performed cytotoxicity analysis and participated in discussion.
¶To whom correspondence should be addressed.
Jon S. Thorson, E-mail: jsthorson{at}pharmacy.wisc.edu
www.pnas.org/cgi/doi/10.1073/pnas.0503270102
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
L. Wang, B. A. Wible, X. Wan, and E. Ficker Cardiac Glycosides as Novel Inhibitors of Human Ether-a-go-go-Related Gene Channel Trafficking J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 525 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bohorov, H. Andersson-Sand, J. Hoffmann, and O. Blixt Arraying glycomics: a novel bi-functional spacer for one-step microscale derivatization of free reducing glycans Glycobiology, December 1, 2006; 16(12): 21C - 27C. [Abstract] [Full Text] [PDF] |
||||